Nanopharm-logo-with-signature-Pantone (1)
Search
Close this search box.

15 Nov 2014

Structural Dynamics of Fluticasone Propionate Processing

Share

This comprehensive research study delves into the structural relaxation of micronized Fluticasone Propionate (FP) under various lagering conditions and its subsequent influence on the aerodynamic particle size distribution (APSD) of binary and tertiary carrier-based dry powder inhaler (DPI) formulations. The study meticulously investigates the changes in physicochemical, surface interfacial properties, and amorphous disorder levels of FP samples under different conditions. The findings suggest that environmental conditions during the lagering of FP can significantly impact its physicochemical and interfacial properties, thereby influencing the performance of binary and tertiary carrier-based dry powder inhaler formulations. This research provides valuable insights and a deeper understanding of the process-induced structural disorder, particle adhesion, and mechanical activation, which are crucial in the pharmaceutical industry.

Related Posts

Innovation & Insights

Interview with Jane Provis Evans, Head cGMP services at Nanopharm

In the ever-evolving world of pharmaceuticals, the importance of stringent quality control cannot be overstated. This interview with Jane Provis-Evans, Head of cGMP Analysis at Nanopharm, sheds light on the critical role of cGMP testing in the development and optimization of drug-device combinations, particularly for orally inhaled and nasal drug products (OINDPs). With the launch of Nanopharm’s new GMP services, the company is well-positioned to help clients bring innovative treatments to patients.

Read More »